ArtiQ, a spin-off from the Belgian university KU Leuven, is a leading innovative software company dedicated to enhancing the diagnosis and monitoring of patients with respiratory conditions. Moreover, ArtiQ strives to streamline and optimize respiratory clinical trials for pharmaceutical companies. Through the development and provision of cutting-edge AI-first software, ArtiQ empowers traditional respiratory devices and processes. In April 2024, ArtiQ was acquired by Clario, a leading healthcare research and technology company. This collaboration allows ArtiQ to broaden its reach globally across various clinical trials and sponsors, aiming to extend its impact beyond respiratory care and foster positive outcomes in healthcare worldwide.
| Website | https://clario.com/ |
| Revenue | $1.1 billion |
| Employees | 16 (4 on RocketReach) |
| Founded | 2019 |
| Technologies | |
| Industry | Hospitals and Health Care, Health Care, Pulmonary function tests, Information Technology, Respiratory problems, Software, Lung diseases, Artificial Intelligence, Digital Health, Diagnostics, Decision support systems |
| Keywords | Patient Monitoring, Respiration Monitoring, Medical Software, Healthcare It, Healthtech, Pulmonary Diagnostics, Digital Health, Remote Patient Monitoring, Clinical Decision Support, Medical Technology, Clinical Software, Telehealth, Lung Health, Medical Devices Software, Healthcare Analytics, Data Driven Healthcare, Artificial Intelligence Healthcare, Software As A Medical Device |
Looking for a particular ArtiQ employee's phone or email?
The ArtiQ annual revenue was $1.1 billion in 2026.
Valerie Hemberg is the COO and CFO of ArtiQ.
4 people are employed at ArtiQ.